Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Róbert Maráz is active.

Publication


Featured researches published by Róbert Maráz.


Pathology & Oncology Research | 2009

Predicting non-sentinel lymph node status after positive sentinel biopsy in breast cancer: What model performs the best in a Czech population?

Oldřich Coufal; Tomáš Pavlík; Pavel Fabian; Rita Bori; Gábor Boross; István Sejben; Róbert Maráz; Jaroslav Koča; Eva Krejčí; Iva Horáková; Vendula Foltinová; Pavlína Vrtělová; Vojtech Chrenko; Wolde Eliza Tekle; Mária Rajtár; Mihály Svébis; Vuk Fait; Gábor Cserni

Several models have previously been proposed to predict the probability of non-sentinel lymph node (NSLN) metastases after a positive sentinel lymph node (SLN) biopsy in breast cancer. The aim of this study was to assess the accuracy of two previously published nomograms (MSKCC, Stanford) and to develop an alternative model with the best predictive accuracy in a Czech population. In the basic population of 330 SLN-positive patients from the Czech Republic, the accuracy of the MSKCC and the Stanford nomograms was tested by the area under the receiver operating characteristics curve (AUC). A new model (MOU nomogram) was proposed according to the results of multivariate analysis of relevant clinicopathologic variables. The new model was validated in an independent test population from Hungary (383 patients). In the basic population, six of 27 patients with isolated tumor cells (ITC) in the SLN harbored additional NSLN metastases. The AUCs of the MSKCC and Stanford nomograms were 0.68 and 0.66, respectively; for the MOU nomogram it reached 0.76. In the test population, the AUC of the MOU nomogram was similar to that of the basic population (0.74). The presence of only ITC in SLN does not preclude further nodal involvement. Additional variables are beneficial when considering the probability of NSLN metastases. In the basic population, the previously published nomograms (MSKCC and Stanford) showed only limited accuracy. The developed MOU nomogram proved more suitable for the basic population, such as for another independent population from a mid-European country.


Orvosi Hetilap | 2009

Analysis of predictive tools for further axillary involvement in patients with sentinel lymph node positive small (≤15 mm) invasive breast cancer

Gábor Cserni; Rita Bori; István Sejben; Gábor Boross; Róbert Maráz; Mihály Svébis; Mária Rajtár; Eliza Tekle Wolde; Éva Ambrózay

Small breast cancers often require different treatment than larger ones. The frequency and predictability of further nodal involvement was evaluated in patients with positive sentinel lymph nodes and breast cancers < or =15 mm by means of 8 different predictive tools. Of 506 patients with such small tumors 138 with positive sentinel nodes underwent axillary dissection and 39 of these had non-sentinel node involvement too. The Stanford nomogram and the micrometastatic nomogram were the predictive tools identifying a small group of patients with low probability of further axillary involvement that might not require completion axillary lymph node dissection. Our data also suggest that the Tenon score can separate subsets of patients with a low and a higher risk of non-sentinel node metastasis. Predictive tools based on multivariate models can help in omitting completion axillary dissection in patients with low risk of non-sentinel lymph node metastasis based on their small tumor size.


Pathology & Oncology Research | 2013

Selective Ductectomy for the Diagnosis and Treatment of Intraductal Papillary Lesions Presenting with Single Duct Discharge

Róbert Maráz; Gábor Boross; É. Ambrózay; Mihály Svébis; Gábor Cserni

Solitary ductal papilloma of the breast, although considered a benign disorder has a potential association with carcinomas. We studied and analyzed the role of selective ductectomy (SD) for the diagnosis and treatment of intraductal lesions presenting with single duct discharge and ductography suggestive of intraductal (papillary) lesions. During a ten-year-period, files of patients presenting with single (or rarely dual) duct discharge were retrospectively reviewed. The examinations included mammography, ductography and ultrasonography and cytology of the fluid discharged from the duct in all patients. Patients treated with SD were considered further and their histological diagnosis and treatment were analyzed. The series included 100 patients. In 6 cases malignancy was found in the specimen consisting of four in situ and two invasive ductal carcinomas. These 6 patients had a second operation and this was followed by adjuvant treatment. Nine further patients had atypical ductal hyperplasia in or around papillomas and one patient had lobular neoplasia around her papilloma. In the present series, the incidence of carcinoma associated with the clinical suspicion of papillary lesions was 6%, and further 10% had low grade neoplastic proliferations resulting in the diagnosis of atypical papillomas or atypical ductal hyperplasia or lobular neoplasia around the papilloma, indicating that single duct discharge may be a symptom a malignancy, and that ductal papillomas have malignant potential. For such a low risk and grade of malignancy simple follow-up could be one option, but in some cases SD could be applied to relieve the patients from symptoms and establish a diagnosis.


Hungarian Journal of Surgery | 2016

Az emlőrák korszerű sebészi kezelése. III. Emlőrák-konszenzuskonferencia

György Lázár; Attila Bursics; Zoltán Farsang; László Harsányi; Csaba Kósa; Róbert Maráz; Zoltán Mátrai; Attila Paszt; Gábor Pavlovics; Róbert Tamás

Absztrakt Az emlőrak sebeszi terapiajat napjainkban es a jovőben is az egyre precizebb diagnosztikus modszerek es az egyre hatasosabb onkologiai kezelesi eljarasok hatarozzak meg. Az emlőmegtartas es az onkoplasztikai elvek alkalmazasa egyre szelesebb korű; az axilla sebeszi kezeleseben az őrszemnyirokcsomo-biopszia az elsődleges, az axillaris blokkdissectio (ABD) indikacioja tovabb szűkult, es a sugarkezeles bizonyos esetekben az ABD alternativaja lett. Kozlemenyunkben a III. Emlőrak-konszenzuskonferencia tartalmara epulve, a legfrissebb nemzetkozi tanulmanyok es szakertői javaslatokat figyelembe veve foglaljuk ossze az emlőrak sebeszi kezelesevel kapcsolatos ajanlasainkat.


Ejso | 2017

The role of preoperative axillary ultrasound and fine-needle aspiration cytology in identifying patients with extensive axillary lymph node involvement

Róbert Maráz; Tamás Zombori; Éva Ambrózay; Gábor Cserni

INTRODUCTION In the recent past, both clinically node-positive and node-negative but sentinel node-positive patients underwent axillary lymph node dissection (ALND), although the two groups seem to have substantially different degree of nodal involvement. METHODS Data on consecutive primary breast cancer patients with documented axillary ultrasound (AXUS) results who underwent ALND between January 2003 and December 2015 either because of AXUS-guided fine needle aspiration (A-FNAC) results or because of a positive sentinel lymph node were retrospectively analysed. RESULTS After exclusions, 316 patients staged by SNB and ALND with negative AXUS or A-FNAC (group A) were compared with 159 patients having positive A-FNAC results (group B). Tumour size and the proportion of mastectomies were greater, histological grade higher and lymphovascular invasion more frequent in Group B, where palpable lymph nodes were also more common. The proportion of cases with extensive nodal involvement (pN2 and pN3 cases) was about 3 times as much in Group B (63%) than in Group A (18%). Removal of the 50 patients with palpable lymph nodes from the analysis did not greatly influence these proportions: 60% and 19% extensive nodal involvements were noted, respectively. In this series, patients with suspicious AXUS and negative A-FNAC had more often extensive nodal involvement (25%) than AXUS negative patients (17%). CONCLUSIONS Patients in whom axillary metastases are detected by ultrasound-guided biopsy have significantly more involved nodes than SLNB-positive patients, and therefore are likely to benefit from axillary treatment.


American Surgeon | 2004

Use and limitations of a nomogram predicting the likelihood of non-sentinel node involvement after a positive sentinel node biopsy in breast cancer patients.

Lajos Kocsis; Mihály Svébis; Gábor Boross; Mária Sinkó; Róbert Maráz; Mária Rajtár; Gábor Cserni


Japanese Journal of Clinical Oncology | 2004

Axillary Sentinel Node and Tumour-related Factors Associated with Non-sentinel Node Involvement in Breast Cancer

Gábor Cserni; Tomasz Burzykowski; Vincent Vinh-Hung; Lajos Kocsis; Gábor Boross; Mária Sinkó; Miklós Tarján; Rita Bori; Mária Rajtár; Eliza Tekle; Róbert Maráz; Béla Baltás; Mihály Svébis


Pathology & Oncology Research | 2014

Internal Mammary Sentinel Node Biopsy in Breast Cancer. Is it Indicated

Róbert Maráz; Gábor Boross; J. Pap-Szekeres; Mária Rajtár; É. Ambrózay; Gábor Cserni


Pathology & Oncology Research | 2013

Multi-Institutional Comparison of Non-sentinel Lymph Node Predictive Tools in Breast Cancer Patients with High Predicted Risk of Further Axillary Metastasis

Gábor Cserni; Rita Bori; Róbert Maráz; Marjut Leidenius; Tuomo J. Meretoja; Päivi Heikkilä; Peter Regitnig; Gero Luschin-Ebengreuth; Janez Zgajnar; Andraz Perhavec; Barbara Gazic; György Lázár; Tibor Takács; András Vörös; Riccardo A. Audisio


Magyar sebészet | 2010

Az emlőrák korszerű sebészi kezelése – II. Konszenzuskonferencia

György Lázár; István Besznyák; Gábor Boross; Zoltán Farsang; Gusztáv Gulyás; Ferenc Jakab; Róbert Maráz; Béla Márkus; László Tóth

Collaboration


Dive into the Róbert Maráz's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

István Besznyák

Memorial Hospital of South Bend

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge